The Board of Directors of Haemonetics Corporation has authorized a buyback plan on August 10, 2022.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
84.74 USD | -0.38% | -0.20% | -0.94% |
Apr. 04 | Haemonetics Gets FDA Clearance for New TEG 6s Global Hemostasis-HN Cartridge | MT |
Apr. 04 | Haemonetics Corporation Receives FDA Clearance for New TEG®? 6s Global Hemostasis - HN Cartridge | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-0.94% | 4.32B | |
-3.79% | 187B | |
-2.56% | 108B | |
-4.60% | 67.71B | |
+11.12% | 53.07B | |
+15.29% | 47.36B | |
+6.01% | 39.73B | |
+11.23% | 28.56B | |
+2.28% | 26.55B | |
+15.97% | 25.13B |
- Stock Market
- Equities
- HAE Stock
- News Haemonetics Corporation
- Haemonetics Corporation authorizes a Buyback Plan.